CXCL13 and neoplasm: Moreover, while intratumoral artLCMV-TRP2 treatment of Ctrl mice promoted tumor control and cured four out of nine mice in long-term, Cxcl13-Cre Il33fl/fl mice failed to control the tumors (Fig. 6b, c).